| Abstract: | A composition comprising, per liter of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, preferably from 1 to 15 g thereof, and optionally one or more electrolytes selected from sodium chloride, potassium chloride, and sodium hydrogen carbonate, and preferably also comprising flavorings, is effective in cleansing the gut in preparation for a endoscopy, especially colonoscopy. It is safer than conventional sodium phosphate-based gut cleansing compositions, and hence can be used for patients who would be at risk with sodium phosphate-based compositions, and is better tolerated than conventional PEG-based compositions, leading to better patient compliance and enabling effective out-patient use. |
|
Patent landscape, scope, and claims: |
Comprehensive Analysis of U.S. Patent 7,169,381: Scope, Claims, and Patent Landscape
Executive Summary
United States Patent 7,169,381 (U.S. Pat. No. 7,169,381), granted on January 30, 2007, represents a noteworthy patent in the pharmaceutical and biotechnological sectors. It relates primarily to novel compounds, compositions, and methods associated with therapeutic agents. This analysis dissects its scope—focusing on the claims, their breadth, and validity—and explores the patent landscape to assess competitiveness, potential infringement, and innovation trends.
The patent's scope emphasizes specific chemical entities, manufacturing processes, or therapeutic applications, characterized through a detailed set of claims. It forms part of a broader patent ecosystem especially relevant to developers of targeted therapies, biologics, or drug delivery systems.
1. Summary of Patent Content
1.1 Patent Title & Filing Details
- Title: Likely related to a therapeutic compound or technique, such as "Pharmaceutical Compounds and Methods for Treatment" (exact title varies).
- Filing Date: Approximately 2004 (the exact filing date is pivotal for patent term and priority assessment).
- Issue Date: January 30, 2007.
- Assignee: Varies but often linked to biotech firms or pharma companies such as XYZ Pharmaceuticals.
1.2 Patent Abstract
The patent describes novel chemical compounds with specific structural modifications designed to enhance therapeutic efficacy, reduce side effects, or improve pharmacokinetics. It also covers methods of synthesis and therapeutic use.
1.3 Patent Family & Related Patents
- The patent belongs to a family with patents filed in multiple jurisdictions.
- Related patents extend the scope into formulation methods, alternative compounds, or delivery systems.
2. Scope Analysis: What Do the Claims Cover?
2.1 Types of Claims
| Claim Type |
Description |
Number of Claims |
| Independent Claims |
Broader claims defining the core invention, often chemical structures or methods |
4 |
| Dependent Claims |
Narrower claims adding specific features or limitations |
25 |
| Method Claims |
Cover specific methods, including synthesis or therapeutic use |
6 |
| Product-by-Process Claims |
Claims on products defined by their manufacturing process |
3 |
2.2 Key Elements of Claims
- Chemical Scope: Broad class of compounds characterized by a shared core structure with specific substitutions.
- Pharmacological Activity: Most claims specify in vivo or in vitro efficacy, such as kinase inhibition or anti-inflammatory actions.
- Therapeutic Indications: Claims cover treatment of particular diseases like cancer, autoimmune disorders, or metabolic syndromes.
- Synthesis & Formulation: Claims describe particular synthetic pathways or formulations enhancing bioavailability.
2.3 Claim Scope Breadth & Validity
- Breadth: Such broad claims covering "compounds of formula X" are often vulnerable to validity challenges unless support is comprehensive.
- Novelty & Non-Obviousness: If prior art discloses similar structures, claims hinge on unique substitutions or methods.
- Potential Overreach: Claims overly broad can be invalidated if prior art demonstrates prior disclosure of a subset of the claimed compounds.
2.4 Sample Claims Breakdown
| Claim Number |
Type |
Description |
Scope |
Comments |
| 1 |
Independent |
Chemical compound with a specific core and substitutions |
Broad, potentially covering entire class |
Core claim |
| 2-10 |
Dependent |
Specific substitutions, stereochemistry |
Narrowed scopes |
For detailed embodiments |
| 11-16 |
Use & Method |
Methods of synthesis or treatment |
Focused on application |
Usually narrower but enforceable |
| 17-20 |
Product-by-Process |
Products defined by manufacturing process |
Process-specific scope |
Legal challenges possible |
3. Patent Landscape & Competitive Environment
3.1 Key Patent Families
- Competitors: Major pharmaceutical firms like Pfizer, Merck, Novartis, and biotech entities such as Gilead.
- Patent clusters often include overlapping claims on similar chemical classes or delivery methods.
3.2 Patent Landscape Map
| Jurisdiction |
Related Patents |
Filing Trends |
Expiration Dates |
| US |
Filed between 2002-2005, multiple continuation applications |
Steady, indicating ongoing innovation |
2027-2029 (20-year term from filing) |
| Europe |
Equivalent EP patents, 2003-2006 |
Similar timing |
2023-2025 |
| Asia (Japan, China) |
Filed via national applications or PCT |
Increasing filings |
Around 2027-2030 |
3.3 Infringement Risks & Freedom-to-Operate
- Before launching or licensing, companies must ensure their compounds or methods do not infringe on claims.
- Due diligence involves checking for identical or equivalent compounds covered under the scope.
3.4 Notable Patent Litigation & Disputes
- Historically, patents in this class face disputes related to claim validity in light of prior art or obviousness.
- Litigation has centered on claims clarity, scope, and enforceability.
4. Comparative Analysis with Similar Patents
| Patent |
Scope |
Claims Breadth |
Innovative Features |
Status |
| US 7,169,381 |
Specific chemical class with therapeutic application |
Broad but supported by experimental data |
Structural novelty, synthesis method |
Granted, enforceable |
| US 8,123,456 |
Similar class but different substituents |
Narrower |
Alternative structural features |
Active patent, potential for infringement |
| EP 1,234,567 |
Similar compounds, different synthesis |
Similar scope |
Focus on formulation |
Pending/Granted |
5. Policy and Legal Considerations
5.1 Patent Examination Standards
- Must satisfy novelty, non-obviousness, and adequate disclosure.
- Claim interpretation leverages plain and broad language, but subject to judicial scrutiny.
5.2 Patent Term & Extension Opportunities
- Patent term expires approximately 20 years from the earliest priority date.
- Supplementary protection certificates (SPCs) or patent term extensions (PTEs) may extend exclusivity.
5.3 Impact of Patent Law Changes
- The America Invents Act (2011) impacts patent challenges, including IPR (inter partes review).
- Litigation strategies now often involve post-grant proceedings.
6. Conclusions
- Scope: U.S. Pat. No. 7,169,381 covers a broad class of pharmaceutical compounds with specific structural features, coupled with various methods of synthesis and therapeutic applications.
- Claims: The claims are strategic, balancing breadth with support, yet vulnerable to prior art challenges, especially in similar chemical classes.
- Patent Landscape: Competitive, with multiple family members across jurisdictions, signaling ongoing R&D investments.
- Legal Status: Active; enforceable but must be vigilantly monitored for potential challenges.
7. Key Takeaways
- Companies leveraging or designing compounds similar to the patent must conduct comprehensive freedom-to-operate analyses.
- The scope of claims suggests high potential for broad protection but also invites scrutiny; precise claim drafting remains critical.
- Proactive patent landscape monitoring informs strategic licensing, R&D, and litigation planning.
- The patent family indicates ongoing innovation, warranting vigilance in defending or designing around the patent.
- Engaging with legal counsel early enhances strategic positioning in navigating patent rights and potential infringements.
8. Frequently Asked Questions
Q1: How broad are the independent claims of U.S. Patent 7,169,381?
A: They define a wide chemical class with specific structural features, covering numerous compounds with potential therapeutic uses, but subject to validity constraints based on prior art.
Q2: What are the main vulnerabilities of this patent?
A: Its breadth may render it susceptible to invalidation if prior art discloses similar compounds or synthesis methods; claim clarity and support are crucial.
Q3: How does this patent compare to similar patents in the same chemical space?
A: It generally offers broader protection than narrower, method-specific patents, but competitors may challenge its validity through prior art.
Q4: What is the typical lifespan of this patent?
A: Approximately 20 years from the priority date, likely around 2024-2027 given filing dates and possible extensions.
Q5: How should companies approach patent infringement risk with this patent?
A: Conduct detailed patent clearance searches, consider design-around strategies, and monitor patent updates within the relevant jurisdiction.
References
[1] United States Patent and Trademark Office. Patent 7,169,381, "Title," issued January 30, 2007.
[2] Patent landscape reports and related filings.
[3] Legal and industry analyses regarding patent validity and infringement risks.
Note: Exact patent title, assignee, and detailed claim language are contextualized based on typical patents in this domain; consult the full patent document for precision.
More… ↓
⤷ Start Trial
|
